Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$73.04 - $95.72 $303 Million - $397 Million
-4,149,675 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $6.24 Million - $7.41 Million
-85,698 Reduced 2.02%
4,149,675 $308 Million
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $7.75 Million - $9.35 Million
-105,422 Reduced 2.43%
4,235,373 $360 Million
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $1.5 Million - $2.08 Million
-23,600 Reduced 0.54%
4,340,795 $373 Million
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $9.45 Million - $11.3 Million
-161,589 Reduced 3.57%
4,364,395 $278 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $15.3 Million - $18.4 Million
-247,225 Reduced 5.18%
4,525,984 $313 Million
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $304 Million - $420 Million
-4,995,489 Reduced 51.14%
4,773,209 $320 Million
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $131 Million - $159 Million
1,577,411 Added 19.26%
9,768,698 $814 Million
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $58.1 Million - $72.4 Million
621,323 Added 8.21%
8,191,287 $776 Million
Q3 2017

Nov 14, 2017

SELL
$109.15 - $138.27 $45.2 Million - $57.2 Million
-413,862 Reduced 5.18%
7,569,964 $884 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,983,826
7,983,826 $1.01 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.